Correspondence 0001193125-22-286748 from VectivBio Holding AG (CIK 0001836379)
VectivBio Holding AG (CIK 0001836379)
Date: Nov. 16, 2022 · CIK: 0001836379 · Accession: 0001193125-22-286748
AI Filing Summary & Sentiment
File numbers found in text: 333-265546
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
November 16, 2022
Via EDGAR
U.S. Securities and Exchange
Commission
Division of Corporation Finance
100 F Street,
N.E.
Washington, D.C. 20549
Attn:
Jane Park
Re:
VectivBio Holding AG
Registration Statement on Form F-3
Filed November 10, 2022
File No. 333-265546
Acceleration Request
Requested Date: November 18, 2022
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the
Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the
above-referenced Registration Statement on Form F-3 (File No. 333-265546) (the “Registration Statement”), to become effective on
November 18, 2022, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the Commission’s staff. The Registrant hereby authorizes Brandon Fenn
of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Brandon Fenn of Cooley LLP at (212)
479-6626.
[Signature page follows]
Very truly yours,
VectivBio Holding AG
By:
/s/ Luca Santarelli
Luca Santarelli
Chief Executive Officer
cc:
Scott Applebaum, VectivBio Holding AG
Brandon Fenn, Cooley LLP
Dayne
Brown, Cooley LLP
Andreas Müller, Homburger AG